Home / Recalls / MACLEODS PHARMA USA, INC / D-0498-2024

D-0498-2024 Class II Ongoing

Recalled by MACLEODS PHARMA USA, INC — Princeton, NJ

Recall Details

Product Type: Drugs
Report Date: May 22, 2024
Initiation Date: May 7, 2024
Termination Date: N/A
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1,048 bottles

Product Description

Losartan Potassium and Hydrochlorothiazide Tablets, USP 50mg /12.5 mg, 1000-count bottle, Rx only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd. Baddi, Himachal Pradesh, INDIA, NDC 33342-050-44

Reason for Recall

Presence of foreign substance: plastic-like substance.

Distribution Pattern

USA Nationwide

Code Information

Lot #: BLK2304A, Exp. 07/31/2025

Other recalls by MACLEODS PHARMA USA, INC

D-0162-2023 Class III — Levofloxacin Tablets, USP 500 mg; 50-count bottles, Rx Only, Manufactured for: M (January 5, 2023)
D-1174-2022 Class II — Eszopiclone Tablets, USP 1 mg, packaged in 30-count bottles, Rx Only, Manufactu (June 16, 2022)
D-1164-2022 Class II — Losartan potassium & Hydrochlorothiazide Tablets 100 mg/25 mg, 30, 90 & 1000 cou (June 10, 2022)
D-0836-2022 Class II — Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/25 mg, a) 30-count (April 15, 2022)
D-0832-2022 Class II — Losartan Potassium Tablets, USP, 25 mg, a) 90-count bottles (NDC # 33342-044-10) (April 15, 2022)
D-0834-2022 Class II — Losartan Potassium Tablets, USP, 100 mg, a) 30-count bottles (NDC # 33342-046-07 (April 15, 2022)
D-0835-2022 Class II — Losartan Potassium & Hydrochlorothiazide Tablets, USP, 50 mg/12.5 mg, a) 30-coun (April 15, 2022)
D-0833-2022 Class II — Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottles (NDC # 33342-045-07) (April 15, 2022)
D-0837-2022 Class II — Losartan Potassium & Hydrochlorothiazide Tablets, USP, 100 mg/12.5 mg, a) 30-cou (April 15, 2022)
D-0762-2022 Class III — Risedronate Sodium Tablets, USP, 5 mg, Rx Only, 30-count bottle, Manufactured fo (March 10, 2022)